Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
BDSX
#3388
Biodesix, Inc. Common Stock
14.760
0
USD
+1.79%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+1.79%
Changement Mensuel
+1.64%
Evolution sur 6 mois
+17.99%
Changement Annuel
+17.99%
Clôture Précédente
14.500
0
Open
14.760
0
Bid
Ask
Low
14.760
0
High
14.760
0
Volume
8
Marchés
Actions des Marchés US
Soins de Santé
BDSX
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
7.3 M
7.33 M
7.33 M
7.96 M
9.86 M
—
Valuation ratios
Enterprise value
-15.03 M
-13.02 M
-18.66 M
43.46 M
48.05 M
59.83 M
Price to earnings ratio
-0.23
-0.12
-0.05
-1.46
-1.46
-3.09
Price to sales ratio
0.14
0.05
0.03
0.67
0.58
1.33
Price to cash flow ratio
-0.2
-0.09
-0.06
-1.93
-2.21
-4.29
Price to book ratio
0.48
0.04
0.03
1.62
-20.83
-19.14
Enterprise value to EBITDA ratio
0.45
0.48
0.66
-1.62
-1.84
-2.32
Profitability ratios
Return on assets %
0.08
0.13
0.13
0.1
0.05
0.4
Return on equity %
0.4
1
10.08
5.06
1.61
17.76
Return on invested capital %
44.17
61.2
66.23
47.83
13.29
188.54
Gross margin %
97.87
99.44
99.96
100
99.75
399.15
Operating margin %
32.55
50.87
48.55
32.39
6.84
138.66
EBITDA margin %
-24.85
-43.64
-41.6
-25.96
-0.03
-111.23
Net margin %
40.39
61.82
57.29
40.04
13.84
172.99
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.76
2.22
2.14
1.84
1.86
8.07
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.2
0.2
0.23
0.25
0.33
1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.37
0.43
0.53
0.53
0.54
2.03
Long term debt to total equity ratio
1.74
3.32
41.11
27.36
19.25
91.03
Per share metrics
Operating cash flow per share
0.63
1.17
0.9
1.18
-0.1
3.15
EBIT per share
-1.09
-1.26
-1.33
-0.94
-0.27
-3.8
EBITDA per share
-0.78
-1.07
-1.14
-0.75
-0
-2.96
Total debt per share
—
—
—
—
—
—
Cash per share
4.04
2.4
2.83
2.21
2.51
9.96
Net current asset value per share
6.09
4.04
4.42
4.45
4.31
17.23
Tangible book value per share
-0
-1.27
-2.56
-2.36
-2.18
-8.37
Working capital per share
3.88
2.23
2.36
2.03
2
8.61
Book value per share
3.22
1.51
0.16
0.23
0.33
2.22
Nouvelles
Biodesix publie une étude de validation de biomarqueur de nodule pulmonaire
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Here's Why Investors Continue to Hold Pediatrix Medical Stock
Biodesix à la conférence TD Cowen : expansion des diagnostics pulmonaires
Biodesix at TD Cowen Conference: Lung Diagnostics Expansion
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
Canaccord réitère sa recommandation sur Biodesix après de solides résultats au T4
Canaccord reiterates Biodesix stock rating on strong Q4 results
3 Best Stocks to Buy Today with 125%+ Upside, 2/27/2026, According to Top Analysts - TipRanks.com
William Blair relève sa recommandation sur Biodesix avec une dynamique d’exécution
William Blair upgrades Biodesix stock rating on execution momentum